Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response

Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response

Cancer treatment-related adverse events (AEs) are sometimes associated with outcomes for cancer patients, especially with the newest therapies such as target therapy and immunotherapy. A few years ago, the first-line therapy for hormone-receptor-positive metastatic breast cancer (mBC) patients has b...

Full description

Bibliographic Details
Main Authors: Mariangela Pasqualoni, Armando Orlandi, Antonella Palazzo, Giovanna Garufi, Maria Chiara Cannizzaro, Letizia Pontolillo, Sergio Pannunzio, Claudia Cutigni, Pietro Sollena, Francesco Federico, Emilio Bria, Giampaolo Tortora
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
breast cancer
CDK4/6 inhibitor
skin adverse event
vitiligo
lymphocytic infiltration
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1067264/full

Similar Items

Similar Items